PAPER Haller S, Montandon ML, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Lovblad KO, Giannakopoulos P
SEARCH RESULTS
330919 RESULTS
PAPER Rábano A, Rodal I, Cuadros R, Calero M, Hernández F, Ávila J
Argyrophilic grain pathology as a natural model of tau propagation.
J Alzheimers Dis. 2014;40 Suppl 1:S123-33. PubMed: 24577470PAPER Troussière AC, Wallon D, Mouton-Liger F, Yatimi R, Robert P, Hugon J, Hannequin D, Pasquier F, Paquet C
Who needs cerebrospinal biomarkers? A national survey in clinical practice.
J Alzheimers Dis. 2014;40(4):857-61. PubMed: 24577469PAPER de Cristóbal J, García-García L, Delgado M, Pérez M, Pozo MA, Medina M
Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging.
J Alzheimers Dis. 2014;40 Suppl 1:S79-89. PubMed: 24577468PAPER Gharbiya M, Trebbastoni A, Parisi F, Manganiello S, Cruciani F, D'Antonio F, De Vico U, Imbriano L, Campanelli A, De Lena C
Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography.
J Alzheimers Dis. 2014;40(4):907-17. PubMed: 24577467PAPER Balasa M, Sánchez-Valle R, Antonell A, Bosch B, Olives J, Rami L, Castellví M, Molinuevo JL, Lladó A
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
J Alzheimers Dis. 2014;40(4):919-27. PubMed: 24577466PAPER de Oliveira FF, Bertolucci PH, Chen ES, Smith MC
Brain-Penetrating Angiotensin-Converting Enzyme Inhibitors and Cognitive Change in Patients with Dementia due to Alzheimer's Disease.
J Alzheimers Dis. 2014 Feb 20; PubMed: 24577465PAPER Farr SA, Erickson MA, Niehoff ML, Banks WA, Morley JE
Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.
J Alzheimers Dis. 2014;40(4):1005-16. PubMed: 24577464PAPER Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B
Long-term metformin usage and cognitive function among older adults with diabetes.
J Alzheimers Dis. 2014;41(1):61-8. PubMed: 24577463PAPER Royall DR, Palmer RF
The temporospatial evolution of neuritic plaque-related and independent tauopathies: implications for dementia staging.
J Alzheimers Dis. 2014;40(3):541-9. PubMed: 24577462PAPER Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Cunningham R, Singh M, O'Bryant SE
The impact of APOE status on relationship of biomarkers of vascular risk and systemic inflammation to neuropsychiatric symptoms in Alzheimer's disease.
J Alzheimers Dis. 2014;40(4):887-96. PubMed: 24577461PAPER Yakhia M, König A, van der Flier WM, Friedman L, Robert PH, David R
Actigraphic motor activity in mild cognitive impairment patients carrying out short functional activity tasks: comparison between mild cognitive impairment with and without depressive symptoms.
J Alzheimers Dis. 2014;40(4):869-75. PubMed: 24577460PAPER Jacquin A, Binquet C, Rouaud O, Graule-Petot A, Daubail B, Osseby GV, Bonithon-Kopp C, Giroud M, Béjot Y
Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke.
J Alzheimers Dis. 2014;40(4):1029-38. PubMed: 24577459PAPER Bracco L, Bessi V, Padiglioni S, Marini S, Pepeu G
Do cholinesterase inhibitors act primarily on attention deficit? A naturalistic study in Alzheimer's disease patients.
J Alzheimers Dis. 2014;40(3):737-42. PubMed: 24577458PAPER Noh Y, Seo SW, Jeon S, Lee JM, Kim JH, Kim GH, Cho H, Yoon CW, Kim HJ, Ye BS, Kim ST, Choe YS, Lee KH, Kim JS, Ewers M, Weiner MW, Lee JH, Werring DJ, Kang DR, Kim CS, Na DL
White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.
J Alzheimers Dis. 2014;40(4):877-86. PubMed: 24577457Current Filters
No filters selected